We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Micropacemaker Treats Fetal Heart Block

By HospiMedica International staff writers
Posted on 22 Apr 2015
A new study describes the first fully implantable micropacemaker designed for dealing with potentially fatal fetal heart block.

Developed by researchers at Children’s Hospital Los Angeles (CHLA; CA, USA) and the University of Southern California (USC; Los Angeles, USA), the miniature pacemaker creates the potential to prevent miscarriages and premature births for those afflicted with fetal heart block, potentially without causing harm to the fetus or to the mother. More...
The micropacemaker, which has already undergone pre-clinical testing, has been designated a humanitarian use device exemption by the US Food and Drug Administration (FDA). The investigators anticipate first human use of the device in the near future.

Although congenital heart block can be diagnosed in utero, all attempts to treat the condition with a standard pacemaker have so far failed, since the size of an adult pacemaker requires that only a small portion be implanted in the fetus, while the electronics remain externalized. This design has uniformly failed, likely due to fetal movement causing the electrodes to become dislodged from the heart. The study describing the fetal micropacemaker was published in the March 2015 issue of Heart Rhythm.

“Up until now, the pacemaker devices that have been used in an attempt to treat this condition in a fetus were designed for adults,” said lead author pediatric cardiologist Yaniv Bar-Cohen, MD, of CHLA. “We have lacked an effective treatment option for fetuses.”

“Building on our experience of using microfabrication techniques to create biomedical devices, we have developed a micropacemaker small enough to reside entirely within the fetus,” said study coauthor Gerald Loeb, MD, a professor of biomedical engineering at the Viterbi School of Engineering at USC. “This will allow the fetus to move freely without risk of dislodging the electrodes.”

Congenital heart block is a defect of the heart’s electrical system that originates in the developing fetus. Within the right atrium of a normal heart is a natural pacemaker that sends an electrical stimulus travels from the pacemaker (SA node) to the ventricles (AV node). If the transmission of the signal is impeded (heart block or an AV block), the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed. If the heart block occurs in the fetus or newborn, the condition is known as congenital heart block.

Related Links:

Children’s Hospital Los Angeles
University of Southern California



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.